Long-term results with growth hormone therapy in idiopathic hypopituitarism.
More than 30 years after its introduction, growth hormone (GH) treatment is well established in children with GH deficiency. Nevertheless, the long-term results of this therapy, expressed as height, are generally considered unsatisfactory. We report on results obtained in a group of GH-deficient children who were treated with daily injections of recombinant GH within the first 5 years of life and who reached an adult height very close to their target height. The full catch-up growth to the target height demonstrated in these patients suggests that replacement therapy should be started early and continued until adulthood. Height at onset of puberty is an important variable which might significantly influence the adult height. The significant and prolonged influence of birth weight on growth response to GH therapy underlines the important role of fetal growth in planning early treatment of GH-deficient children.
Bernasconi
S
S
Department of Paediatrics, Universities of Modena and Reggio Emilia, Messina, Italy. berna@unimo.it
Arrigo
T
T
Wasniewsk
M
M
Ghizzoni
L
L
Ruggeri
C
C
Di Pasquale
G
G
Vottero
A
A
De Luca
F
F
D001827:Body Height; D002648:Child; D002675:Child, Preschool; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011627:Puberty; D013997:Time Factors; D016896:Treatment Outcome
D019382:Human Growth Hormone